Rebimastat (BMS-275291) is a novel, potent and sulfhydryl-based 2nd-generation inhibitor of matrix metalloproteinase (MMP) which selectively inhibits MMPs (MMP 1, 2, 8, 9, and 14), thus inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. It has potential antineoplastic activity.

纯度：≥98%

CAS：259188-38-0